Risk of Long COVID in hospitalized individuals treated with remdesivir for acute COVID-19

Risk of Long COVID in hospitalized individuals treated with remdesivir for acute COVID-19

Abstract Long COVID comprises a multisystem syndrome occurring after COVID-19. This retrospective cohort study investigated whether remdesivir given during acute COVID-19 is associated with reduced incidence of Long COVID, including in immunocompromised subgroups. The HealthVerity database of hospit...

Full description

Saved in:
Bibliographic Details
Main Authors: Mark Berry, Amanda M. Kong, Roger Paredes, Julie Paone, Rohan Shah, Rebecca Taylor, Essy Mozaffari, Rikisha Gupta, Robert L. Gottlieb, Lourdes Mateu, Mazin Abdelghany, Jason D. Goldman, Anand P. Chokkalingam
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
COVID-19
Long COVID
Antiviral therapy
Remdesivir
Immunocompromising conditions
Online Access:https://doi.org/10.1038/s41598-025-06052-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-06052-3

Similar Items